Literature DB >> 1350045

Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniae.

R A Lock1, D Hansman, J C Paton.   

Abstract

Previous studies on Streptococcus pneumoniae have established that the pneumococcal proteins autolysin (N-acetylmuramyl-L-alanine amidase) and pneumolysin both contribute significantly to the virulence of the organism. In the present work, autolysin and a defined toxoid derivative of pneumolysin were tested, individually and in combination, for efficacy in a mouse model as antigens protecting against challenge with virulent, wild-type S. pneumoniae. While each antigen alone provided significant protection, the degree of protection was not increased when the antigens were administered together. In an additional experiment, mice were challenged with a genetically-modified mutant strain of pneumococcus unable to express active pneumolysin. Pre-immunization of such mice with autolysin failed to provide any significant protection against the challenge. The results of this study suggest that the most important contribution made by autolysin to the virulence of S. pneumoniae may be its role in mediating the release of pneumolysin from the pneumococcal cytoplasm during infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350045     DOI: 10.1016/0882-4010(92)90116-6

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  31 in total

1.  The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin.

Authors:  P Balachandran; S K Hollingshead; J C Paton; D E Briles
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

2.  An Arcanobacterium (Actinomyces) pyogenes mutant deficient in production of the pore-forming cytolysin pyolysin has reduced virulence.

Authors:  B H Jost; J G Songer; S J Billington
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

Review 3.  Next generation pneumococcal vaccines.

Authors:  Kristin L Moffitt; Richard Malley
Journal:  Curr Opin Immunol       Date:  2011-04-21       Impact factor: 7.486

4.  CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.

Authors:  Aras Kadioglu; William Coward; M Joseph Colston; Colin R A Hewitt; Peter W Andrew
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

5.  Enterococcus faecalis antigens in human infections.

Authors:  Y Xu; L Jiang; B E Murray; G M Weinstock
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

6.  The autolysin-encoding gene (lytA) of Streptococcus pneumoniae displays restricted allelic variation despite localized recombination events with genes of pneumococcal bacteriophage encoding cell wall lytic enzymes.

Authors:  A M Whatmore; C G Dowson
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae.

Authors:  J E Alexander; R A Lock; C C Peeters; J T Poolman; P W Andrew; T J Mitchell; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice.

Authors:  Dennis O Gor; Xuedong Ding; Qing Li; John R Schreiber; Michael Dubinsky; Neil S Greenspan
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  The genome of Streptococcus mitis B6--what is a commensal?

Authors:  Dalia Denapaite; Reinhold Brückner; Michael Nuhn; Peter Reichmann; Bernhard Henrich; Patrick Maurer; Yvonne Schähle; Peter Selbmann; Wolfgang Zimmermann; Rolf Wambutt; Regine Hakenbeck
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

10.  Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin.

Authors:  María del Mar García-Suárez; María Dolores Cima-Cabal; Noelia Flórez; Pilar García; Rafael Cernuda-Cernuda; Aurora Astudillo; Fernando Vázquez; Juan R De los Toyos; F Javier Méndez
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.